Public flocks to get vaccines as controversy surrounds A/H1N1 ‘pandemic’

The number of people in Romania infected with A/H1N1 flu has reached 6,470, and the death toll 102, according to the Ministry of Health.

The number of new cases confirmed over the 24 hours prior to the statement on Friday was 84, with two deaths.

Most of the cases were in Bucharest (36), followed by Botosani (18), while other cities had four or fewer confirmed cases.

Apart from the Matei Bals Institute, where there are three medical offices for vaccination, two other centers were opened in Bucharest at the Public Health Institute and the Cantacuzino Institute.

New vaccination centers were also opened at Lahovary hospital and Colentina hospital.

Read more about

NASTY: The documentary about Ilie Năstase selected for Cannes Film Festival

read more

In the days following the death of actor Toni Tecuceanu at the beginning of January, apparently as a result of the virus, vaccination points in the city were crowded with people wanting the jab.

Adrian Streinu Cercel, state secretary in the Ministry of Public Health, said the actor’s medical records included the A/H1N1 virus along with various other complications.

However, the actor’s brother and some of his colleagues came forward to say that the published death results were mere spin, intended to convince people to buy the vaccine. Paul Tecuceanu said his brother’s death might not have been the result of A/H1N1 and that official papers did not cite the flu as the cause of the death.

Moreover, none of the people who had come into contact with Toni Tecuceanu had subsequently come down with the virus.

Meanwhile, at European level, there are doubts that A/H1N1 should even be classified as a pandemic.

The Health Committee of the EU Parliament has unanimously passed a resolution calling for an inquiry into the matter.

The motion was introduced by Dr. Wolfgang Wodarg, former SPD member of the German Bundestag and now chairman of the European Parliament Health Committee.

The text of the resolution, which was just passed by a sufficient number in the Council of Europe Parliament, states, “In order to promote their patented drugs and vaccines against flu, pharmaceutical companies influenced scientists and official agencies responsible for public health standards to alarm governments worldwide and make them squander tight health budgets on inefficient vaccine strategies and needlessly expose millions of healthy people to the risk of an unknown number of side effects of insufficiently tested vaccines.”

Otilia Haraga